The first passively managed, pure-play exchange-traded fund (ETF) for cannabis investing is now publicly available to investors.
On Tuesday (July 9), Innovation Shares’ The Cannabis ETF (ARCA:THCX) launched on NYSE Arca. The THCX focuses on companies in the legal cannabis, hemp and cannabidiol (CBD) industry. It follows the Innovation Labs Cannabis Index and rebalances monthly.
The index lists 35 stocks that are “expected to benefit from the rise in value of the global cannabis market, which is estimated to reach US$630 billion by 2040,” according to the press release.
“With several regulatory catalysts on the horizon in the US and abroad, the current cannabis environment presents an exciting opportunity for investors,” said Innovation Shares managing director Matt Markiewicz in the press release.
He added that the portfolio is largely composed of companies that are cashing in on the “CBD boom” and are actively “cultivating hemp, providing extraction services or by using CBD for applications in the pharmaceutical, health and consumer wellness markets.”
The index includes some of the largest names in the cannabis industry, with 19 Canadian licensed producers and a market capitalization of just under US$80 billion.
Here are the top 5 holdings on the THCX:
- Cronos Group (NASDAQ:CRON,TSX:CRON) – 7.81 percent
- GW Pharmaceuticals (OTC Pink:GWPRF) – 7.76 percent
- Canopy Growth (NYSE:CGC,TSX:WEED) – 7.71 percent
- Aurora Cannabis (NYSE:ACB,TSX:ACB) – 7.68 percent
- Tilray (NASDAQ:TLRY) – 7.42 percent
The THCX ETF launch comes shortly after the announcement of another cannabis-focused ETF, the CNBS Cannabis ETF from Amplify ETFs. CNBS will also trade on NYSE Arca and is expected to launch sometime next week, according to ETF.com.
The introduction of both THCX and CNBS represents a growing market for cannabis-focused ETFs in both Canada and the United States, along with increased competition. Earlier this year, two new ETFs, the Evolve US Marijuana ETF from Evolve Funds Group (NEO:USMJ) and the Horizons US Marijuana Index ETF from Horizons ETFs Management (NEO:HMUS), were launched. The assets under management for the two ETFs sit at US$4.09 million and US$16.05 million, respectively as of Thursday (July 11).
Other US-based cannabis ETFs include the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) issued by AdvisorShares earlier this year, and the ETFMG Alternative Harvest ETF (ARCA:MJ), which was launched in 2015 and was the first cannabis-focused ETF traded in the US, according to ETF.com.
The assets under management for the two ETFs are at US$59.89 million and US$1.1 billion, respectively.
On Thursday, another cannabis coplay was added to the THCX list. Canadian medical cannabis company Aleafia Health (TSX:ALEF,OTCQX:ALEAF,FWB:ARAH) announced its presence on the THCX and is currently weighted one percent.
On Tuesday, THCX opened at US$24.35 and closed at US$24.56. The THCX closed at US$23.90 on Thursday (July 11).
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).